HCA Healthcare Slashes 2026 Profit Guidance on Uninsured Patient Surge

What happened

HCA Healthcare released preliminary second-quarter results and lowered its full-year 2026 earnings per share guidance to a range of $28.70 to $30.50, down from the previous $29.10 to $31.50. The company also cut its expected net income to between $6.3 billion and $6.7 billion, compared with prior guidance of $6.5 billion to $7 billion. HCA attributed the reduction to a shift in its payer mix, treating significantly more uninsured patients in the second quarter. This change had an estimated negative impact of about $400 million on income before taxes during the quarter. The company now expects the increase in uninsured patients stemming from the end of ACA subsidies to lower its income by between $1 billion and $1.2 billion this year, up from an earlier projection of $600 million to $900 million. HCA also noted a decline in surgical volumes, with inpatient surgeries falling 2.3% and outpatient procedures dropping 3.4% year-over-year. Despite these headwinds, the company anticipates second-quarter revenues of about $20.2 billion, up from $18.6 billion the same time last year, and net income just below $1.7 billion, about $50 million higher year-over-year, both above Wall Street consensus expectations.

Why it matters

The guidance cut reveals how the expiration of enhanced ACA premium tax credits in January is hitting hospital operators harder than initially forecast. Millions of Americans left the ACA exchanges this year after subsidies expired and premiums rose sharply, leading to a surge in uninsured patients. For HCA, this translates to higher uncompensated care costs and lower demand for elective procedures, directly pressuring profitability. The company's revised outlook-particularly the near-doubling of its expected ACA-related income loss-signals that hospitals may have underestimated the financial toll of this coverage disruption. Investors now face uncertainty about whether similar pressures are building at other hospital chains. The decline in surgical volumes compounds these concerns, as elective procedures are typically higher-margin revenue drivers. While HCA still expects year-over-year revenue and earnings growth, the magnitude of the downward revision suggests the operating environment has deteriorated faster than management anticipated.

Bigger picture

HCA's announcement spooked investors across the hospital sector, dragging down shares of Community Health Systems, Tenet Healthcare, and Universal Health Services. The ripple effect extended beyond hospitals: medtech leaders like Intuitive Surgical, Abbott Laboratories, Stryker, and Medtronic also saw their stocks tumble, as the surgical volume decline raises questions about demand for medical devices and equipment. The broader health care industry is grappling with the fallout from ACA subsidy expiration, which has left millions newly uninsured and shifted the payer mix toward less profitable or uncompensated care. This dynamic poses a structural challenge for hospitals and their suppliers, especially if elective procedure volumes remain weak. HCA's experience serves as an early indicator of how the coverage disruption is reshaping the health care landscape, with implications for hospitals, insurers, device makers, and investors alike.

What to watch

Investors should monitor HCA's official second-quarter earnings release on July 24 for more detail on patient volumes, payer mix trends, and cost management strategies. Watch for commentary on whether the surge in uninsured patients is stabilizing or accelerating, and how the company plans to offset the profit headwinds. Broader industry data on ACA enrollment, uninsured rates, and elective procedure trends will be critical to understanding whether HCA's challenges are company-specific or sector-wide. Earnings reports from other hospital operators-particularly Community Health Systems, Tenet Healthcare, and Universal Health Services-will reveal whether the payer mix shift is hitting the entire industry or if HCA is uniquely exposed. Finally, keep an eye on legislative or regulatory developments around ACA subsidies, as any reinstatement or extension could materially improve the operating environment for hospitals and related health care companies.